| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8227(14)70733-8 |
| P698 | PubMed publication ID | 25550057 |
| P50 | author | Ronald Ching Wan Ma | Q43809750 |
| P2093 | author name string | Alice P S Kong | |
| Juliana C N Chan | |||
| Andrea Luk | |||
| Wing-Yee So | |||
| Peter C Y Tong | |||
| Risa Ozaki | |||
| Patrick Wong | |||
| Gary T C Ko | |||
| Rebecca Wong | |||
| Cherry Chiu | |||
| Francis C C Chow | |||
| Greg Lyubomirsky | |||
| Harriet Chung | |||
| JADE Collaborative Study Group | |||
| Troels Wolthers | |||
| P2860 | cites work | Monitoring the Targets of the St Vincent Declaration and the Implementation of Quality Management in Diabetes Care: the DiabCare Initiative | Q22242411 |
| Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States | Q26859746 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
| 10-year follow-up of intensive glucose control in type 2 diabetes | Q29615973 | ||
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
| What can we learn from the recent blood glucose lowering megatrials? | Q33558383 | ||
| From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program | Q33577432 | ||
| Consultation length in general practice: cross sectional study in six European countries | Q33932453 | ||
| Peer support for self-management of diabetes improved outcomes in international settings | Q34026321 | ||
| Translation research for chronic disease: the case of diabetes | Q34112252 | ||
| Stress Hormones: Their Interaction and Regulation | Q34248023 | ||
| Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study | Q34419027 | ||
| Medical care and payment for diabetes in China: enormous threat and great opportunity. | Q34437761 | ||
| Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control | Q34711122 | ||
| The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry. | Q34893020 | ||
| Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial | Q35021652 | ||
| Diabetes-related distress and physical and psychological health in chinese type 2 diabetic patients | Q35043781 | ||
| Changing office practice and health care systems to facilitate diabetes self-management | Q35120348 | ||
| Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis | Q35824836 | ||
| Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus | Q36649245 | ||
| Multidrug treatment of type 2 diabetes: a challenge for compliance | Q36783845 | ||
| Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS) | Q37067081 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice | Q37231566 | ||
| The value of self-monitoring of blood glucose: a review of recent evidence | Q37397247 | ||
| The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach | Q37760873 | ||
| Management of type 2 diabetes: new and future developments in treatment | Q37894446 | ||
| Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis | Q38017479 | ||
| Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge | Q38051841 | ||
| Effects of telephone-based peer support in patients with type 2 diabetes mellitus receiving integrated care: a randomized clinical trial | Q38431256 | ||
| Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum | Q39413300 | ||
| Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program | Q39983936 | ||
| Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study | Q41776334 | ||
| Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Card | Q41824843 | ||
| Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort | Q42202570 | ||
| Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS). | Q44569632 | ||
| Promotion of improvement as a science | Q44950287 | ||
| Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients | Q44975136 | ||
| The renoprotective effects of structured care in a clinical trial setting in type 2 diabetic patients with nephropathy | Q44997788 | ||
| Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? | Q45285707 | ||
| Assessing psychosocial distress in diabetes: development of the diabetes distress scale | Q45285718 | ||
| Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus | Q46727650 | ||
| Effect of a multifactorial intervention on mortality in type 2 diabetes | Q46767642 | ||
| Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy | Q46869014 | ||
| The Joint Asia Diabetes Evaluation (JADE) Program: a web-based program to translate evidence to clinical practice in Type 2 diabetes | Q46882596 | ||
| Attending the diabetes center is associated with increased 5-year survival probability of diabetic patients: the Verona Diabetes Study. | Q51018233 | ||
| Achievement of goals in U.S. diabetes care, 1999-2010. | Q51045064 | ||
| Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. | Q51090960 | ||
| The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. | Q51479755 | ||
| End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry. | Q51934249 | ||
| Association of statin use and development of renal dysfunction in type 2 diabetes--the Hong Kong Diabetes Registry. | Q53177023 | ||
| Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. | Q53254408 | ||
| Modified end-stage renal disease risk score for Chinese type 2 diabetic patients—the Hong Kong Diabetes Registry | Q58209738 | ||
| Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients | Q58209991 | ||
| Relationship Between Patient Medication Adherence and Subsequent Clinical Inertia in Type 2 Diabetes Glycemic Management | Q61850368 | ||
| Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus | Q68134802 | ||
| Diabetes patient education: a meta-analysis and meta-regression | Q75283741 | ||
| The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice | Q84563923 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | information technology | Q11661 |
| P304 | page(s) | S295-304 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Diabetes Research and Clinical Practice | Q15750054 |
| P1476 | title | Delivery of integrated diabetes care using logistics and information technology--the Joint Asia Diabetes Evaluation (JADE) program | |
| P478 | volume | 106 Suppl 2 |
| Q55129245 | Depressive Symptoms, Co-Morbidities, and Glycemic Control in Hong Kong Chinese Elderly Patients With Type 2 Diabetes Mellitus. |
| Q52382361 | Determinants of hospitalization in Chinese patients with type 2 diabetes receiving a peer support intervention and JADE integrated care: the PEARL randomised controlled trial. |
| Q90126975 | Diabetes, Care Homes, and the Influence of Technology on Practice and Care Delivery in Care Homes: Systematic Review and Qualitative Synthesis |
| Q38767914 | Intelligent Internet-based information system optimises diabetes mellitus management in communities |
| Q28076239 | Prevention and Care Programs Addressing the Growing Prevalence of Diabetes in China |
| Q48355319 | Regular mailing of personalized feedback reports improves glycemic control in diabetes: A randomized controlled trial. |
| Q42656667 | The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios. |
| Q30251480 | Using Large Diabetes Databases for Research |
| Q38793971 | Virtual obesity collaborative with and without decision-support technology |
Search more.